GUIDELINES FOR THE DOSAGE OF NEUROLEPTICS .1. CHLORPROMAZINE EQUIVALENTS OF ORALLY-ADMINISTERED NEUROLEPTICS

被引：175

作者：

REY, MJ

SCHULZ, P

COSTA, C

DICK, P

TISSOT, R

机构：

来源：

关键词：

D O I：

10.1097/00004850-198904000-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：95 / 104

页数：10

共 41 条

[1] ABUZZAHAB FS, 1977, PSYCHOPHARMACOLOGY B, V13, P72
[2] APPLETON WS, 1982, J CLIN PSYCHIAT, V43, P12
[3] WHAT IS THE BEST MAINTENANCE DOSE OF NEUROLEPTICS IN SCHIZOPHRENIA
BALDESSARINI, RJ
DAVIS, JM
[J]. PSYCHIATRY RESEARCH, 1980, 3 (02) : 115 - 122
[4] DRUG TREATMENT IN SCHIZOPHRENIA
BAN, TA
[J]. CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1971, 16 (06): : 473 - 485
[5] CASSANO G B, 1977, Psychopharmacology Bulletin, V13, P41
[6] CLAGHORN JL, 1983, PSYCHOPHARMACOL BULL, V19, P138
[7] ANTIPSYCHOTIC MEDICATIONS - CLINICAL USE AND EFFECTIVENESS
CORDOBA, OA
[J]. HOSPITAL PRACTICE, 1981, 16 (12): : 99 - &
[8] THE CLINICAL USE OF ANTIPSYCHOTIC MEDICATIONS
COYLE, JT
[J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (05) : 993 - 1009
[9] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
CREESE, I
BURT, DR
SNYDER, SH
[J]. SCIENCE, 1976, 192 (4238) : 481 - 483
[10] DAVIS J, 1983, NEUROLEPTICS NEUROCH